Shared Research logo
Taiwanese regulatory authorities approve the provision of cancer immunocellular therapy using MEDINET's technology at a new medical facility
Q3 FY09/23 report update
Announcement regarding investment in kokoromil Co., Ltd.
Get in touch
TRC Center Bldg, 9F 6-1-1 Heiwajima, Ota-ku Tokyo, Japan 143-0006
Shifting from Immuno-Cell Therapy Total Support Service to the Contracted Cell Manufacturing Business; sale and development of cell medicinal products